Early Life
Christian Angermayer was born in Wiesau, Bavaria, Germany, on April 26, 1978. At the age of 20, he dropped out of the University of Bayreuth, where he was studying biochemistry, to co-found Ribopharma AG with two professors.
Rise to Success
Angermayer's early career was marked by the founding of Ribopharma, which merged with Alnylam in 2003, making him a multimillionaire at 25. Following Ribopharma, he co-founded Angermayer, Brumm & Lange Group (ABL) before establishing Apeiron Investment Group in 2012. Apeiron has become his primary vehicle for investments in various sectors, including life sciences, fintech, and emerging technologies.
Key Business Strategies
Angermayer's investment strategy involves a global, multi-strategy approach, with a focus on identifying and supporting innovative companies. Apeiron Investment Group invests across the entire company lifecycle, from seed investments to large-scale growth rounds and investments in listed companies. He is known for being hands-on, reliable, and a long-term partner to the companies he invests in. Angermayer's interests include biotechnology, psychedelics-based medicine, longevity research, and cryptocurrency.
Philanthropy
Christian Angermayer is a member of the World Economic Forum’s Young Global Leaders program, the Milken Institute Young Leaders Circle, and the Presidential Advisory Council of Rwanda. He is involved in discussions on crucial topics and issues, including the “Angermayer Policy and Innovation Forum”.
